Table of Contents
ISRN Dermatology
Volume 2011 (2011), Article ID 813513, 3 pages
http://dx.doi.org/10.5402/2011/813513
Review Article

Nevogenesis: A Benign Metastatic Process?

1Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
2Melanoma Program, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA
3Interdisciplinary Stem Cell Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA

Received 13 February 2011; Accepted 8 March 2011

Academic Editors: F. M. Camacho, A. Firooz, and J. F. Val Bernal

Copyright © 2011 Andrew L. Ross et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Grichnik, “Melanoma, nevogenesis, and stem cell biology,” Journal of Investigative Dermatology, vol. 128, no. 10, pp. 2365–2380, 2008. View at Publisher · View at Google Scholar · View at PubMed
  2. J. M. Grichnik, “Hypothesis letter: the reason sentinel and lymph node dissections do not improve melanoma mortality,” Journal of Investigative Dermatology, vol. 129, no. 3, pp. 779–781, 2009. View at Publisher · View at Google Scholar · View at PubMed
  3. D. A. Biddle, H. L. Evans, B. L. Kemp et al., “Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma,” American Journal of Surgical Pathology, vol. 27, no. 5, pp. 673–681, 2003. View at Publisher · View at Google Scholar
  4. S. Andreola and C. Clemente, “Nevus cells in axillary lymph nodes from radical mastectomy specimens,” Pathology Research and Practice, vol. 179, no. 6, pp. 616–618, 1985. View at Google Scholar
  5. N. C. Bautista, S. Cohen, and K. H. Anders, “Benign melanocytic nevus cells in axillary lymph nodes: a prospective incidence and immunohistochemical study with literature review,” American Journal of Clinical Pathology, vol. 102, no. 1, pp. 102–108, 1994. View at Google Scholar
  6. K. F. Carson, D. R. Wen, P. X. Li et al., “Nodal nevi and cutaneous melanomas,” American Journal of Surgical Pathology, vol. 20, no. 7, pp. 834–840, 1996. View at Publisher · View at Google Scholar
  7. D. Fontaine, W. Parkhill, W. Greer, and N. Walsh, “Nevus cells in lymph nodes: an association with congenital cutaneous nevi,” American Journal of Dermatopathology, vol. 24, no. 1, pp. 1–5, 2002. View at Publisher · View at Google Scholar
  8. J. B. Holt, O. P. Sangueza, E. A. Levine et al., “Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi,” American Journal of Clinical Pathology, vol. 121, no. 1, pp. 58–63, 2004. View at Publisher · View at Google Scholar · View at PubMed
  9. B. G. Howell, J. E. Lipa, and D. M. Ghazarian, “Intracapsular melanoma: a new pitfall for sentinel lymph node biopsy,” Journal of Clinical Pathology, vol. 59, no. 8, pp. 891–892, 2006. View at Google Scholar
  10. J. W. Patterson, “Nevus cell aggregates in lymph nodes,” American Journal of Clinical Pathology, vol. 121, no. 1, pp. 13–15, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. G. Argenziano, H. P. Soyer, S. Chimenti et al., “Dermoscopy of pigmented skin lesions: results of a consensus meeting via the internet,” Journal of the American Academy of Dermatology, vol. 48, no. 5, pp. 679–693, 2003. View at Publisher · View at Google Scholar · View at PubMed
  12. J. L. Abernethy, H. P. Soyer, H. Kerl, J. L. Jorizzo, and W. L. White, “Epidermotropic metastatic malignant melanoma simulating melanoma in situ: a report of 10 examples from two patients,” American Journal of Surgical Pathology, vol. 18, no. 11, pp. 1140–1149, 1994. View at Google Scholar
  13. O. Straume, L. Sviland, and L. A. Akslen, “Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma,” Clinical Cancer Research, vol. 6, no. 5, pp. 1845–1853, 2000. View at Google Scholar
  14. I. Betlloch, C. Amador, E. Chiner, F. Pasquau, J. L. Calpe, and A. Vilar, “Eruptive melanocytic nevi in human immunodeficiency virus infection,” International Journal of Dermatology, vol. 30, no. 4, p. 303, 1991. View at Google Scholar
  15. V. López, I. Molina, J. M. Martín, N. Santonja, M. J. Forner, and E. Jordá, “Eruptive nevi in a patient receiving cyclosporine A for psoriasis treatment,” Archives of Dermatology, vol. 146, no. 7, pp. 802–804, 2010. View at Google Scholar
  16. H. J. Bovenschen, M. Tjioe, H. Vermaat et al., “Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals,” British Journal of Dermatology, vol. 154, no. 5, pp. 880–884, 2006. View at Publisher · View at Google Scholar · View at PubMed
  17. J. N. W. N. Barker and D. M. MacDonald, “Eruptive dysplastic naevi following renal transplantation,” Clinical and Experimental Dermatology, vol. 13, no. 2, pp. 123–125, 1988. View at Google Scholar
  18. N. Onsun, S. Saracoglu, C. Demirkesen, Y. B. Kural, and U. Atilganoglu, “Eruptive widespread spitz nevi: can pregnancy be a stimulating factor?” Journal of the American Academy of Dermatology, vol. 40, no. 5, part 2, pp. 866–867, 1999. View at Google Scholar
  19. C. M. Lanschuetzer, M. Emberger, R. Hametner et al., “Pathogenic mechanisms in epidermolysis bullosa naevi,” Acta Dermato-Venereologica, vol. 83, no. 5, pp. 332–337, 2003. View at Publisher · View at Google Scholar
  20. A. R. Cardones and J. M. Grichnik, “α-melanocyte-stimulating hormone-Induced eruptive nevi,” Archives of Dermatology, vol. 145, no. 4, pp. 441–444, 2009. View at Publisher · View at Google Scholar · View at PubMed
  21. A. Sekulic, M. B. Colgan, M. D. P. Davis, D. J. DiCaudo, and M. R. Pittelkow, “Activating BRAF mutations in eruptive melanocytic naevi,” British Journal of Dermatology, vol. 163, no. 5, pp. 1095–1098, 2010. View at Publisher · View at Google Scholar · View at PubMed